000 | 01867 a2200529 4500 | ||
---|---|---|---|
005 | 20250515005634.0 | ||
264 | 0 | _c20060427 | |
008 | 200604s 0 0 eng d | ||
022 | _a0960-894X | ||
024 | 7 |
_a10.1016/j.bmcl.2005.11.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJones, Philip | |
245 | 0 | 0 |
_aPharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABA(A) alpha5 inverse agonist for cognitive dysfunction. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cFeb 2006 |
||
300 |
_a872-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aGABA Agonists _xchemical synthesis |
650 | 0 | 4 | _aGABA-A Receptor Agonists |
650 | 0 | 4 | _aHydrolysis |
650 | 0 | 4 |
_aIsoxazoles _xchemical synthesis |
650 | 0 | 4 | _aMacaca mulatta |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 |
_aProtein Subunits _xagonists |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTissue Distribution |
650 | 0 | 4 |
_aTriazines _xchemical synthesis |
700 | 1 | _aAtack, John R | |
700 | 1 | _aBraun, Matthew P | |
700 | 1 | _aCato, Brian P | |
700 | 1 | _aChambers, Mark S | |
700 | 1 | _aO'Connor, Desmond | |
700 | 1 | _aCook, Susan M | |
700 | 1 | _aHobbs, Sarah C | |
700 | 1 | _aMaxey, Robert | |
700 | 1 | _aSzekeres, Helen J | |
700 | 1 | _aSzeto, Nicola | |
700 | 1 | _aWafford, Keith A | |
700 | 1 | _aMacLeod, Angus M | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 16 _gno. 4 _gp. 872-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2005.11.012 _zAvailable from publisher's website |
999 |
_c15926745 _d15926745 |